Skip to main content

CORRECTION article

Front. Immunol., 06 February 2024
Sec. Vaccines and Molecular Therapeutics
Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1375028

Corrigendum: Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao

This article is a correction to:

  1. Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao

    1. Read original article
Hoi Man Ng&#x;Hoi Man Ng1†Chon Lok Lei&#x;Chon Lok Lei2†Siyi Fu&#x;Siyi Fu2†Enqin LiEnqin Li2Sek In LeongSek In Leong1Chu Iong NipChu Iong Nip1Nga Man ChoiNga Man Choi1Kai Seng LaiKai Seng Lai1Xi Jun Tang*Xi Jun Tang3*Chon Leng Lei*Chon Leng Lei1*Ren-He Xu*Ren-He Xu2*
  • 1Laboratory Department, Kiang Wu Hospital, Macao, Macao SAR, China
  • 2Faculty of Health Sciences, University of Macau, Macao, Macao SAR, China
  • 3Laboratory Department, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Zhuhai, China

A Corrigendum on
Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao

By Ng HM, Lei CL, Fu S, Li E, Leong SI, Nip CI, Choi NM, Lai KS, Tang XJ, Lei CL and Xu R-H (2023). Front. Immunol. 14:1131985. doi: 10.3389/fimmu.2023.1131985

In the published article, there was an error in affiliation 3. Instead of “Laboratory Department, Zhuhai Hospital of Combined Traditional Chinese and Western Medicine, Zhuhai, China”, it should be “Laboratory Department, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Zhuhai, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: SARS-CoV-2, inactivated vaccine, mRNA vaccine, heterologous vaccinations, antibodies, spike proteins, nucleocapsid proteins, Macao

Citation: Ng HM, Lei CL, Fu S, Li E, Leong SI, Nip CI, Choi NM, Lai KS, Tang XJ, Lei CL and Xu R-H (2024) Corrigendum: Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao. Front. Immunol. 15:1375028. doi: 10.3389/fimmu.2024.1375028

Received: 23 January 2024; Accepted: 24 January 2024;
Published: 06 February 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Ng, Lei, Fu, Li, Leong, Nip, Choi, Lai, Tang, Lei and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Chon Leng Lei, steffilei@kwh.org.mo; Ren-He Xu, renhexu@um.edu.mo; Xi Jun Tang, 13709689195@163.com

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.